Oncovalent Therapeutics
Latest round
- Seed
Last raised
- Sep 2020
Total raised
- Undisclosed
Investors
- 1
About Oncovalent Therapeutics
, formerly known as SUMO Bioscience, Inc. operates as an early-stage small molecule company focused on oncology therapeutics. The company changed its name from SUMO Bioscience, Inc. to Oncovalent Therapeutics Inc. in 2020.
Who invested in Oncovalent Therapeutics
1 investor across 1 round
See all investors in Oncovalent Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 9, 2020
Amount
Undisclosed
Investors
Questions about Oncovalent Therapeutics
Who invested in Oncovalent Therapeutics?
Oncovalent Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oncovalent Therapeutics raised?
Oncovalent Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oncovalent Therapeutics last raise money?
Oncovalent Therapeutics's most recent round on record is a Seed, in Sep 2020.
What does Oncovalent Therapeutics do?
, formerly known as SUMO Bioscience, Inc.
Where is Oncovalent Therapeutics headquartered?
Oncovalent Therapeutics is headquartered in Thousand Oaks, US.
Which VCs invest in companies like Oncovalent Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oncovalent Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Oncovalent Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.